Journal of Lipid Research, Vol 32, 1529-1535, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

Restriction isotyping of human apolipoprotein A-IV: rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat

JE Hixson and PK Powers
Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, TX 78228-0147.

Genetic polymorphisms of apolipoprotein A-IV (apoA-IV) have been detected by isoelectric focusing of serum proteins. Because genetic variation in apoA-IV has significant effects on lipid risk factors, we used restriction enzyme isoform genotyping (restriction isotyping) to determine apoA-IV isoform genotypes at the DNA level for a large population (n = 509). In contrast to isoelectric focusing methods, restriction isotyping relies on nucleotide differences, enabling unambiguous typing of known isoforms and detection of new alleles that mimic other isoforms with shared charge properties. To determine genotypes for the common A-IV-1 isoform (Gln at aa position 360) and A- IV-2 isoform (360His), we used a mismatched primer for polymerase chain reaction (PCR) to introduce a restriction site (PvuII) that distinguishes each isoform. Using a portion of the same PCR reaction, we used HinfI to distinguish isoforms with Thr at position 347 (347Thr) versus Ser (347Ser). In surveys for these common genotypes, we detected heterozygotes for an allele with an insertion of 12 bp. Nucleotide sequencing showed that this allele is identical to the A-IV-0 isoform that inserts a hydrophilic repeat (Glu Gln Gln Gln) in a conserved region near the carboxy terminus. In addition, we discovered a new allele with a 12 bp deletion that removes a repeat (Glu Gln Gln Gln) from the same region. Nucleotide sequencing showed that this allele removes an acidic charge relative to A-IV-1, so we have named this isoform A-IV-2*. This isoform has not been discovered at the protein level, perhaps due to shared charge properties with A-IV-2 isoforms.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. S.C. Korf, L. R. White, P. Scheltens, and L. J. Launer Brain Aging in Very Old Men With Type 2 Diabetes: The Honolulu-Asia Aging Study Diabetes Care, October 1, 2006; 29(10): 2268 - 2274. [Abstract] [Full Text] [PDF]

				E. S.C. Korf, L. R. White, P. Scheltens, and L. J. Launer Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study Hypertension, July 1, 2004; 44(1): 29 - 34. [Abstract] [Full Text] [PDF]

				M. A Pereira, R. M Weggemans, D. R Jacobs Jr, P. J Hannan, P. L Zock, J. M Ordovas, and M. B Katan Within-person variation in serum lipids: implications for clinical trials Int. J. Epidemiol., June 1, 2004; 33(3): 534 - 541. [Abstract] [Full Text] [PDF]

				L. A. Woollett, D. D. Buckley, L. Yao, P. J. H. Jones, N. A. Granholm, E. A. Tolley, and J. E. Heubi Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans J. Lipid Res., May 1, 2003; 44(5): 935 - 942. [Abstract] [Full Text] [PDF]

				N. Scarmeas, J. Brandt, M. Albert, D. P. Devanand, K. Marder, K. Bell, A. Ciappa, B. Tycko, and Y. Stern Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease Neurology, April 23, 2002; 58(8): 1182 - 1188. [Abstract] [Full Text] [PDF]

				F. Wilkin, N. Gagné, J. Paquette, L. L. Oligny, and C. Deal Pediatric Adrenocortical Tumors: Molecular Events Leading to Insulin-Like Growth Factor II Gene Overexpression J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2048 - 2056. [Abstract] [Full Text]

				E. R. De Oliveirae Silva, M. Kong, Z. Han, C. Starr, E. M. Kass, S.-H. H. Juo, D. Foster, H. M. Dansky, M. Merkel, K. Cundey, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females J. Lipid Res., July 1, 1999; 40(7): 1211 - 1221. [Abstract] [Full Text]

				R. M. Fisher, H. Burke, V. Nicaud, C. Ehnholm, and S. E. Humphries Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II J. Lipid Res., February 1, 1999; 40(2): 287 - 294. [Abstract] [Full Text]

				M. A. Ostos, J. Lopez-Miranda, J. M. Ordovas, C. Marin, A. Blanco, P. Castro, F. Lopez-Segura, J. Jimenez-Pereperez, and F. Perez-Jimenez Dietary fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus J. Lipid Res., December 1, 1998; 39(12): 2493 - 2500. [Abstract] [Full Text]

				R. W. Wissler and J. P. Strong Risk Factors and Progression of Atherosclerosis in Youth Am. J. Pathol., October 1, 1998; 153(4): 1023 - 1033. [Full Text] [PDF]

				R. Carmena-Ramon, J. F. Ascaso, J. T. Real, J. M. Ordovas, and R. Carmena Genetic Variation at the ApoA-IV Gene Locus and Response to Diet in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1266 - 1274. [Abstract] [Full Text] [PDF]

				A. Steinmetz, M. Hermann, J. Nimpf, R. Aebersold, A. Ducret, R. B. Weinberg, and W. J. Schneider Expression and Conservation of Apolipoprotein AIV in an Avian Species J. Biol. Chem., April 24, 1998; 273(17): 10543 - 10549. [Abstract] [Full Text] [PDF]

				S. Jansen, J. Lopez-Miranda, J. Salas, J. M. Ordovas, P. Castro, C. Marin, M. A. Ostos, F. Lopez-Segura, J. A. Jimenez-Pereperez, A. Blanco, et al. Effect of 347-Serine Mutation in Apoprotein A-IV on Plasma LDL Cholesterol Response to Dietary Fat Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1532 - 1538. [Abstract] [Full Text]